Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 08, 2025 05:33 ET | Source: Research and Markets

Patient Engagement in Genomics Research Fuels Growth in Healthcare Segment

Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "Genomics Market by Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow...
December 07, 2025 21:37 ET | Source: Clinuvel Pharmaceuticals Limited

CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies

EXECUTIVE SUMMARY VALLAURIX Research, Development & Innovation Centre to expand its existing facilities and capabilities core focus on accelerating development of liquid long-acting drug delivery...
December 07, 2025 19:54 ET | Source: Skyline Digital Marketing

Skyline Digital Marketing Introduces Proprietary Skyline Methodology to Strengthen Data-Driven Business Growth

Anderson, SC, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Skyline Digital Marketing, an Anderson-based digital growth agency, is introducing its proprietary Skyline Methodology – a four-step framework...
December 07, 2025 08:05 ET | Source: Prime Medicine, Inc.

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...
December 06, 2025 09:30 ET | Source: Genmab A/S

Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)

Media ReleaseCOPENHAGEN, Denmark; December 6, 2025 New two- and three-year EPCORE® NHL-2 follow-up data evaluating epcoritamab in combination with standard of care regimens demonstrate remission in...
December 06, 2025 09:10 ET | Source: SNS Insider pvt ltd

Peptide Therapeutics Market Size to Reach USD 82.19 Billion by 2032; Surging Requirements for Targeted Medicines in Oncology Augment Market Expansion - SNS Insider

Technological advancements in peptide synthesis, expanding R&D pipelines, and strong U.S. market leadership accelerate sector growth at a CAGR of 7.51%.
December 06, 2025 08:30 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting

Adaptive announces deep interventional use of clonoSEQ across abstracts at ASH
December 06, 2025 08:00 ET | Source: Beam Therapeutics

Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting

Updated Data from 31 Adult and Adolescent SCD Patients Treated with risto-cel (Formerly BEAM-101) Show Mean Hemoglobin F (HbF) Induction of >60%, Hemoglobin S (HbS) Reduction to <40%, and...
December 05, 2025 14:40 ET | Source: Global Aerospace

Global Aerospace's SM4 Aviation Safety Program Provides Insight on The Importance of Safety Behaviors and Questions to Ask for Fostering a Culture of Safety Excellence

Morris Plains, NJ, Dec. 05, 2025 (GLOBE NEWSWIRE) -- As safety managers across diverse aviation organizations implement, operate and enhance safety management systems (SMS), the...
December 05, 2025 07:39 ET | Source: Research and Markets

Life Science and Chemical Instrumentation Market Trends and Industry Forecast to 2030 by Technology, End-User and Region

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Life Science and Chemical Instrumentation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ...